HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and fret

Traffic

Volumn 6, Issue 9, 2005, Pages 741-755

  Poole, Emma ^a   Strappe, Padraig ^a   Mok, Hoi Ping ^a   Hicks, Ray ^a   Lever, Andrew M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Centrosome; HIV 1; Packaging signal

Indexed keywords

GAG PROTEIN; RNA; STRUCTURAL PROTEIN; TUBULIN; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CELL NUCLEUS; CELL STRAIN COS1; CELLULAR DISTRIBUTION; CENTRIOLE; CENTROSOME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DNA PACKAGING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; MICROFILAMENT; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN TRANSPORT; RNA STRUCTURE; SIGNAL TRANSDUCTION; VIRUS CORE; VIRUS PARTICLE;

ANIMALS; BINDING SITES; CELL LINE; CELL NUCLEUS; CENTROSOME; CERCOPITHECUS AETHIOPS; COS CELLS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE PRODUCTS, GAG; HIV-1; HUMANS; MICROSCOPY, CONFOCAL; PROTEIN BINDING;

EID: 23844460841     PISSN: 13989219     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2005.00312.x     Document Type: Article

References (60)

1. Cullen BR. Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 1991;65:1053-1056.
2. Kaye JF, Lever AML. Trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. J Virol 1996;70:880-886.
3. Lever A, Gottlinger H, Haseltine W, Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 1989;63:4085-4087.
4. Harrison GP, Lever AML. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 1992;66:4144-4153.
5. Clever J, Sassetti C, Parslow TG. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J Virol 1995;69:2101-2109.
6. De Guzman RN, Wu ZR, Stalling CC, Pappalardo L, Borer PN, Summers MF. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 1998;279:384-388.
7. Zeffman A, Hassard S, Varani G, Lever AML. The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein. J Mol Biol 2000;297:877-893.
8. Pappalardo L, Kerwood DJ, Pelczer I, Borer PN. Three-dimensional folding of an RNA hairpin required for packaging HIV-II. J Mol Biol 1998;282:801-818.
9. Berkowitz RD, Goff SP. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology 1994;202:233-246.
10. Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983;33:153-159.
11. Clavel F, Orenstein JM. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol 1990;64:5230-5234.
12. Aldovini A, Young RA. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol 1990;64:1920-1926.
13. Muriaux D, Mirro J, Nagashima K, Harvin D, Rein A. Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes. J Virol 2002;76:11405-11413.
14. Gorelick RJ, Nigida SM Jr, Bess JW Jr, Arthur LO, Henderson LE, Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol 1990;64:3207-3211.
15. Darlix JL, Gabus C, Nugeyre MT, Clavel F, Barre Sinoussi F. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol 1990;216:00689-699.
16. Campbell S, Vogt VM. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol 1995;69:6487-6497.
17. Wang SW, Aldovini A. RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes. J Virol 2002;76:11853-11865.
18. Rein A. Retroviral RNA packaging: a review. Arch Virol Suppl 1994;9:513-522.
19. Wang SW, Noonan K, Aldovini A. Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses. J Virol 2004;78:716-723.
20. Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA. The double-stranded RNA-binding protein staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol 2000;74:5441-5451.
21. Gallego J, Greatorex J, Zhang H, Yang B, Arunachalam S, Fang J, Seamons J, Pomerantz RJ, Lever AM. Rev binds specifically to a purine loop in the SL1 region of the HIV-1 leader RNA. J Biol Chem 2003;278:40385-40391.
22. Anson DS, Fuller M. Rational development of a HIV-1 gene therapy vector. J Gene Med 2003;5:829-838.
23. Richardson JH, Child LA, Lever AM. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5′ leader region. J Virol 1993;67:3997-4005.
24. Johnson MC, Scobie HM, Ma YM, Vogt VM. Nucleic acid-independent retrovirus assembly can be driven by dimerization. J Virol 2002;76:11177-11185.
25. Levin JG, Grimley PM, Ramseur JM, Berezesky IK. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol 1974;14:152-161.
26. Dorman N, Lever AML. Comparison of viral genomic RNA sorting mechanisms in HIV-1, HIV-2, and MMLV. J Virol 2000;74:11413-11417.
27. Basyuk E, Galli T, Mougel M, Blanchard JM, Sitbon M, Bertrand E. Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev Cell 2003;5:161-174.
28. Fusco D, Accornero N, Lavoie B, Shenoy SM, Blanchard JM, Singer RH, Bertrand E. Single mRNA molecules demonstrate probabilistic movement in living mammalian cells. Curr Biol 2003;13:161-167.
29. Hansen M, Jelinek L, Whiting S, Barklis E. Transport and assembly of gag proteins into Moloney murine leukemia virus. J Virol 1990;64:5306-5316.
30. Ulmer JB, Palace GE. Effects of brefeldin A on the processing of viral envelope glycoproteins in murine erythroleukemia cells. J Biol Chem 1991;266:9173-9179.
31. Pal R, Mumbauer S, Hoke GM, Takatsuki A, Sarngadharan MG. Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1991;7:707-712.
32. Mouland AJ, Xu H, Cui H, Krueger W, Munro TP, Prasol M, Mercier J, Rekosh D, Smith R, Barbarese E, Cohen EA, Carson JH. RNA trafficking signals in human immunodeficiency virus type 1. Mol Cell Biol 2001;21:2133-2143.
33. Borsetti A, Chagen A, Gottlinger HG. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J Virol 1998;72:9313-9317.
34. Rey O, Canon J, Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology 1996;220:530-534.
35. Nermut MV, Wallengren K, Pager J. Localization of actin in Moloney murine leukemia virus by immunoelectron microscopy. Virology 1999;260:23-34.
36. Liu B, Dai R, Tian CJ, Dawson L, Gorelick R, Yu XF. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J Virol 1999;73:2901-2908.
37. Ibarrondo FJ, Choi R, Geng YZ, Canon J, Rey O, Baldwin GC, Krogstad P. HIV type 1 Gag and nucleocapsid proteins. cytoskeletal localization and effects on cell motility. AIDS Res Hum Retroviruses 2001;17:1489-1500.
38. Bukrinskaya A, Brichacek B, Mann A, Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J Exp Med 1998;188:2113-2125.
39. Ott DE, Coren LV, Kane BP, Busch LK, Johnson DG, Sowder RC II, Chertova EN, Arthur LO, Henderson LE. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol 1996;70:7734-7743.
40. Perrin-Tricaud C, Davoust J, Jones IM. Tagging the human immunodeficiency virus gag protein with green fluorescent protein. Minimal evidence for colocalisation with actin. Virology 1999;255:20-25.
41. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002;159:441-452.
42. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993;365:666-669.
43. Paillart JC, Gottlinger HG. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting. J Virol 1999;73:2604-2612.
44. Parent LJ, Cairns TM, Albert JA, Wilson CB, Wills JW, Craven RC. RNA dimerization defect in a Rous sarcoma virus matrix mutant. J Virol 2000;74:164-172.
45. Berthold E, Maldarelli F. Cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J Virol 1996;70:4667-4682.
46. Wu P, Brand L. Resonance energy transfer: methods and applications. Anal Biochem 1994;218:1-13.
47. Larson DR, Ma YM, Vogt VM, Webb WW. Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy. J Cell Biol 2003;162:1233-1244.
48. Marcello A, Cinelli RA, Ferrari A, Signorelli A, Tyagi M, Pellegrini V, Beltram F, Giacca M. Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer. J Biol Chem 2001;276:39220-39225.
49. Matsumoto C, Hamasaki K, Mihara H, Ueno A. A high-throughput screening utilizing intramolecular fluorescence resonance energy transfer for the discovery of the molecules that bind HIV-1 TAR RNA specifically. Bioorg Med Chem Lett 2000;10:1857-1861.
50. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997;15:871-875.
51. Sfakianos JN, LaCasse RA, Hunter E. The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic 2003;4:660-670.
52. Petit C, Giron ML, Tobaly-Tapiero J, Bittoun P, Real E, Jacob Y, Tordo N, De The H, Saib A. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J Cell Sci 2003;116:3433-3442.
53. Ono A, Freed EO. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J Virol 2004;78:1552-1563.
54. Kaye JF, Lever AML. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J Virol 1999;73:3023-3031.
55. Poon DT, Chertova EN, Ott DE. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55 (Gag): functional linkage between translation and RNA packaging. Virology 2002;293:368-378.
56. Levin JG, Rosenak MJ. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci USA 1976;73:1154-1158.
57. Wilk T, Gowen B, Fuller SO. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J Virol 1999;73:1931-1940.
58. Paoletti A, Moudjou M, Paintrand M, Salisbury JL, Bornens M. Most of centrin in animal cells is not centrosome-associated and centrosomal centrin is confined to the distal lumen of centrioles. J Cell Sci 1996;109:3089-3102.
59. Johnson CV, Singer RH, Lawrence JB. Fluorescent detection of nuclear RNA and DNA: implications for genome organization. Methods Cell Biol 1991;35:73-99.
60. Favaro JP, Borg KT, Arrigo SJ, Schmidt MG. Effect of Rev on the intranuclear localization of HIV-1 unspliced RNA. Virology 1998;249:286-296.